superball
![]()
Posts:2
Any estimate of when something like Pemetrexed plus MEK inhibitor might be on the market for treatment
of Advanced NSCLC - EGFR wild, KRAS positive- Lung Cancer. Thanks!
Forums
Copyright © 2021 Global Resource for Advancing Cancer Education
Site by Freelock
Reply # - April 29, 2015, 06:54 AM
Hi superball,
Hi superball,
A check of clinicaltrials.gov reveals a handful of trials either recruiting or waiting to recruit, and one Phase I study combining GSK1120212 with several different chemo regimens, including pemetrexed (Alimta). As a result, it seems likely that any approval of such a combination may come a bit farther down the line.
JimC
Forum moderator